Condition: Alzheimer Disease · Lymphatic Obstruction · Sponsor: MMI (Medical Microinstruments, Inc.)
The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
This description comes directly from the study's public registry record.
Clinical Operations · 8336646276 · clinical.ops@mmimicro.com
Always discuss trial participation with your own doctor first.
| Stanford Medical Center | Palo Alto, California, United States | Recruiting |
| Baptist Health Research Institute | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07178210